Cardia Bioplastics has secured patent protection for its Cardia Compostable, Biohybrid and PPC-starch resin and finished products from Japan, Australia, New Zealand and China Patent and Trademark Offices. Seven new patents were granted during 2014 for Cardia's bioplastics resin formulations and production processes.

These new patents expand Cardia Bioplastics growing intellectual property portfolio of 11 patent families, with 19 patents so far granted in U.S., Australia, China, Japan, New Zealand and South Africa. The patents protect the composition formulation and manufacturing process invented by Cardia's R&D team.

Frank Glatz, managing director of Cardia Bioplastics said: "This marks an important milestone for Cardia Bioplastics. These granted patents protect the intellectual property of the company and further support the technical differentiation of our globally certified Cardia Compostable and independently validated lower carbon foot print Cardia Biohybrid product offering."

"Cardia is collaborating with leading global brand owners to reduce the environmental impact of their packaging. Cardia's Biohybrid technology enables them to reduce the carbon footprint and the use of less oil in their packaging with an environmental benefit while maintaining product performance. Cardia's strong patent position and freedom to operate is a critical requirement for these large global brand owners."

The company believes that the continual expansion of its patent portfolio validates the company's technical capabilities and unique formulation. With rapid global growth of bioplastics use in diverse product applications, Cardia's patent portfolio capitalizes on the demand of leading brand owners where strong intellectual property position is a key requirement.